![Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog](https://i0.wp.com/covidblog.oregon.gov/wp-content/uploads/2022/09/bivalent.jpg?fit=4431%2C2954&ssl=1)
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
![Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant - ABC News Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant - ABC News](https://i.abcnewsfe.com/a/b3d6aa94-b125-48aa-8348-b3c233fe988c/pfizer-biontech-bivalent-booster-file-rt-221_hpMain_20221104-050026_16x9.jpg?w=992)
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant - ABC News
![CCHD now offering a second bivalent COVID-19 booster shot for Vulnerable Populations - Cecil County Health Department CCHD now offering a second bivalent COVID-19 booster shot for Vulnerable Populations - Cecil County Health Department](http://cecilcountyhealth.org/wp-content/uploads/2022/09/Screenshot-2022-09-06-3.52.01-PM.png)
CCHD now offering a second bivalent COVID-19 booster shot for Vulnerable Populations - Cecil County Health Department
![Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City - The Lancet Regional Health – Americas Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/attachment/cd4e0920-cdfa-4b9a-9033-e1b554e7ecfa/gr1.jpg)
Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City - The Lancet Regional Health – Americas
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)